-
1
Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
2
Germline Human Leukocyte Antigen Status is Associated With Immunotherapy-Induced Pneumonitis and Treatment Response in Patients With Non–Small Cell Lung Cancer With High Programmed...
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
3
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
4
Automated Measurement of Coronary Artery Calcifications and Routine Perioperative Blood Tests Predict Survival in Resected Stage I Lung Cancer
Published 2025-03-01“…JTO Clinical and Research Reports…”
Get full text
Article -
5
Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
6
Temporal Trends in the Utilization and Survival Outcomes of Lobar, Segmental, and Wedge Resection for Early-Stage NSCLC, 2004 to 2020
Published 2025-03-01“…JTO Clinical and Research Reports…”
Get full text
Article -
7
Brief Report: Precision Language and Deletion of the “S” Word
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
8
Racial Disparities in Cancer Guideline-Concordant Treatment Using Surveillance, Epidemiology, and End Results Data for Patients With NSCLC
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
9
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
Published 2025-03-01“…JTO Clinical and Research Reports…”
Get full text
Article -
10
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma
Published 2025-03-01“…JTO Clinical and Research Reports…”
Get full text
Article -
11
Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage...
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
12
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
Published 2025-03-01“…JTO Clinical and Research Reports…”
Get full text
Article -
13
Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
14
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
15
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
16
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
Published 2025-03-01“…JTO Clinical and Research Reports…”
Get full text
Article -
17
J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan
Published 2025-03-01“…JTO Clinical and Research Reports…”
Get full text
Article -
18
Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volu...
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
19
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article -
20
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator’s Consortium Registry Analysis
Published 2025-01-01“…JTO Clinical and Research Reports…”
Get full text
Article